Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 2.59% | 139.65 | 0.6% | $670.28m | |
| ABBV | AbbVie, Inc. | 1.53% | 92.44 | 2.1% | $570.88m | |
| PFE | Pfizer Inc. | -0.47% | 35.81 | 0.8% | $552.37m | |
| MRK | Merck & Co., Inc. | -0.41% | 63.08 | 0.6% | $455.76m | |
| BMY | Bristol-Myers Squibb Company | 0.60% | 64.03 | 1.4% | $327.98m | |
| LLY | Eli Lilly and Company | 0.33% | 86.23 | 1.0% | $260.56m | |
| AZN | AstraZeneca PLC Sponsored ADR | -0.14% | 34.60 | 1.3% | $151.97m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.53% | 40.65 | 0.2% | $151.16m | |
| NVS | Novartis AG Sponsored ADR | -0.45% | 85.98 | 0.2% | $133.86m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.07% | 49.29 | 0.1% | $106.70m | |
| SNY | Sanofi Sponsored ADR | -0.75% | 49.26 | 0.2% | $57.25m | |
| LCI | Lannett Company, Inc. | -0.47% | 23.59 | 38.6% | $20.40m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 0.31% | 6.50 | 2.2% | $6.63m | |
| SCMP | Sucampo Pharmaceuticals, Inc. Class A | 2.75% | 10.28 | 14.4% | $5.37m | |
| EPIX | ESSA Pharma Inc | -1.99% | 0.29 | 0.0% | $0.03m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.